Therapeutic goods regulation
The regulatory framework reflects and upholds the Australian community’s expectations around the safety and quality of therapeutic goods on the market.
Latest alerts
- Hazard Alert: Scandinavian Total Ankle Replacement (STAR) Ankle ProsthesisBe alert to an issue affecting all units of the Scandinavian Total Ankle Replacement (STAR) Ankle Prosthesis supplied in the Australian market.
- Counterfeit semaglutide vialsThe TGA has detected fake semaglutide, also known as Ozempic, being illegally imported into Australia.
Latest articles
- Changes to the regulation of sports supplements in medicinal dosage formsFrom 30 November 2023, some sports supplements will be regulated as therapeutic goods and must be included in the Australian Register of Therapeutic Goods (ARTG).
- TGA seizes 40,000 vapes as part of multi-agency operation in QueenslandOn 29 August 2023, the TGA executed multiple warrants on storage units and residences in Brisbane and seized over 40,000 vaping products with an estimated street value of over $1.2 million
- Post-market review of facemasks closedThe COVID-19 pandemic post-market review of facemasks is now finished.
Latest publications
- Public notice of interim decisions on proposed amendments to the Poisons Standard - ACMS#40, ACCS#35, Joint ACMS-ACCS#32 - November 2022Interim decisions and invitation for further comment. Closing date: 3 March 2023
- Pharmacovigilance Inspection Program metrics report: Jan - Dec 2021The TGA Pharmacovigilance Inspection Program (PVIP) metrics report for 2021 is now available.
- Notice of interim decisions on proposed amendments to the Poisons Standard – ACMS #38, ACCS #34, Joint ACMS-ACCS #31 – June 2022Interim decisions and invitation for further comment. Closing date: 24 November 2022
Open consultations
- Consultation: Proposed amendments to the Poisons Standard – ACMS, ACCS and Joint ACMS-ACCS meetings, November 2023Have your say on proposed amendments to the Poisons Standard, to be considered at advisory committees in November 2023.